JPH0581566B2 - - Google Patents

Info

Publication number
JPH0581566B2
JPH0581566B2 JP60177355A JP17735585A JPH0581566B2 JP H0581566 B2 JPH0581566 B2 JP H0581566B2 JP 60177355 A JP60177355 A JP 60177355A JP 17735585 A JP17735585 A JP 17735585A JP H0581566 B2 JPH0581566 B2 JP H0581566B2
Authority
JP
Japan
Prior art keywords
glucosamine
skin
cells
whitening
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60177355A
Other languages
Japanese (ja)
Other versions
JPS6236306A (en
Inventor
Yutaka Mishima
Toshiro Hori
Jun Kawaguchi
Noriaki Kadota
Katsuya Nishimoto
Jusuke Asano
Nagataka Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Priority to JP17735585A priority Critical patent/JPS6236306A/en
Publication of JPS6236306A publication Critical patent/JPS6236306A/en
Publication of JPH0581566B2 publication Critical patent/JPH0581566B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 本発明は色白化粧料に関するものである。 〔従来の技術〕 一般に皮膚に対して日光からの紫外線が照射さ
れると皮膚内の色素細胞メラノサイトにおいてメ
ラニンが著しく生成して皮膚が黒色化する傾向が
ある。このような日焼けによつて生じる皮膚の黒
化の防止、また、メラニン色素の沈着によるシ
ミ、ソバカスを除去することを目的として化粧料
に配合される物質としては、アスコルビン酸類
(特開昭59−65007)、過酸化水素、グルタチオン
(特開昭57−134410)、コロイド硫黄、ハイドロキ
ノン(特開昭59−157009)、コウジ酸(特公昭60
−7961)、桂皮アルデヒド(特開昭58−55414)等
が知られているが、アスコルビン酸類は湿性製品
の如き水分を多く含む系においては酸化されやす
く不安定であり、変色、変臭の原因となりがちで
ある。過酸化水素については過酸化物という特性
上、安全性、保存面、安定性面から充分なものと
は言い難い。グルタチオンやコロイド硫酸は異臭
を放つため色白化粧料へ使用することは避けられ
ている。ハイドロキノンは、細胞毒性が強く安全
性面から充分なものとは言い難い。またコウジ酸
および桂皮アルデヒドは、少量では皮膚の黒化を
防止する効果が小さく色白化粧料への使用におい
て充分なものとは言い難い。近年、カニ殻等から
精製されるグルコサミン塩酸塩がメラニン産生色
素細胞(melanotic型黒色腫細胞)の培養系で、
メラニン生産能の不可逆的な喪失を生じさせるこ
となく色素細胞を白色化させることが見い出され
た(芋川玄爾、三島豊:培養黒色腫細胞内
glucosamine誘導メラニン生成抑制の電顕的解
析.Proc.Jap.Soc.Invest.Derm.,5:103−104,
1980)。グルコサミン塩酸塩の色素細胞に対する
上述の効果は色白化粧料として人体に投与した場
合、ハイドロキノンのように色素細胞のメラニン
産生能を不可逆的に喪失することがないため白斑
のような皮膚への障害が少ないことを示唆するも
のである。しかしながら、グルコサミン塩酸塩の
色素細胞に対する白色化効果を発現さすためには
高濃度のグルコサミン塩酸塩の存在が必要であ
り、また経皮吸収による生体内取り込みが難しい
ため、そのままでは色白化粧料への利用効果が小
さい。 〔発明が解決しようとする問題点〕 発明者等はかかる現状に鑑み、白色化効果が大
きく、しかもその作用が可逆的であり皮膚に対す
る安全性の高い色白化粧料を提供することを目的
として鋭意研究した結果、グルコサミンのアシル
誘導体が色素細胞に対し色白化効果が著しく強
く、しかもその作用が可逆的であることを見い出
し、本発明を完成するに至つた。 〔問題点を解決するための手段〕 すなわち本発明は、 (1) 式
[Industrial Application Field] The present invention relates to fair skin cosmetics. [Prior Art] Generally, when the skin is irradiated with ultraviolet rays from sunlight, melanin is significantly produced in the pigment cell melanocytes in the skin, and the skin tends to turn black. Ascorbic acids (Japanese Unexamined Patent Application Publication No. 1983-1993) are used as substances in cosmetics for the purpose of preventing skin darkening caused by sunburn and removing spots and freckles caused by melanin pigment deposition. 65007), hydrogen peroxide, glutathione (Japanese Patent Publication No. 57-134410), colloidal sulfur, hydroquinone (Japanese Patent Publication No. 59-157009), kojic acid (Japanese Patent Publication No. 1983-157009),
-7961), cinnamaldehyde (Japanese Patent Application Laid-open No. 58-55414), etc. However, ascorbic acids are easily oxidized and unstable in systems containing a lot of water such as wet products, causing discoloration and odor. This tends to be the case. Due to the characteristics of hydrogen peroxide, it is difficult to say that it is sufficient in terms of safety, storage, and stability. Glutathione and colloidal sulfuric acid give off a strange odor, so their use in fairing cosmetics is avoided. Hydroquinone is highly cytotoxic and cannot be said to be sufficient from a safety standpoint. Furthermore, in small amounts, kojic acid and cinnamaldehyde have a small effect in preventing skin darkening, and cannot be said to be sufficient for use in fair skin cosmetics. In recent years, glucosamine hydrochloride purified from crab shells, etc. has been used in culture systems for melanin-producing pigment cells (melanotic melanoma cells).
It was discovered that pigment cells can be whitened without irreversible loss of melanin production ability (Genji Imokawa, Yutaka Mishima: Intracultured Melanoma Cells)
Electron microscopic analysis of glucosamine-induced suppression of melanin production. Proc.Jap.Soc.Invest.Derm., 5:103-104,
1980). The above-mentioned effect of glucosamine hydrochloride on pigment cells is that when administered to the human body as a skin-lightening cosmetic, unlike hydroquinone, it does not irreversibly lose the melanin production ability of pigment cells, so it does not cause skin damage such as vitiligo. This suggests that there are few. However, in order for glucosamine hydrochloride to exhibit its whitening effect on pigment cells, a high concentration of glucosamine hydrochloride is required, and it is difficult to be absorbed into the body through transdermal absorption, so it cannot be used as is in skin-whitening cosmetics. Usage effect is small. [Problems to be solved by the invention] In view of the current situation, the inventors have worked diligently with the aim of providing a skin-whitening cosmetic that has a large whitening effect, is reversible, and is highly safe for the skin. As a result of research, it was discovered that acyl derivatives of glucosamine have a significantly strong skin whitening effect on pigment cells, and that this effect is reversible, leading to the completion of the present invention. [Means for solving the problem] That is, the present invention solves the following problems: (1) Equation

〔作用〕[Effect]

次に本発明の有効成分であるグルコサミン誘導
体のメラニン産生色素細胞(melanotic型黒色腫
細胞)に対する白色化効果を以下の試験例にて実
証する。 実施例 1 テトラ−O−アセチル−グルコサミン塩酸塩 テトラ−O−プロパノイル−グルコサミン塩酸
塩 N−オクタノイル−グルコサミン N−アセチル−1,3,4,6−テトラ−O−
プロピオニルグルコサミン N−アセチル−1,3,4,6−テトラ−O−
ブチリルグルコサミン N−アセチル−1,3,4,6−テトラ−O−
アセチルグルコサミン N−アセチル−3,4,6−トリ−O−ブチリ
ルグルコサミン N−アセチル−3,4,6−トリ−O−プロピ
オニルグルコサミン N−アセチル−3,4,6−トリ−O−アセチ
ルグルコサミン N−アセチル−1−プロピオニルグルコサミン N−ブチリル−1,3,4,6−テトラ−O−
ブチリルグルコサミン O−β−オクタノイル−グルコサミン酢酸塩 N−オクタデカノイル−グルコサミン O−β−オクタデカノイル−グルコサミン塩酸
塩 N−モンタノイル−グルコサミン N−メリシノイル−グルコサミン N−リノレニル−グルコサミン N−エルカニル−グルコサミン N−アセチルグルコサミン グルコサミン塩酸塩 ハイドロキノン コウジ酸 アルコルビン酸 試料液の調製 試験物質は、表1−1と表1−2に示す濃度に
なるよう純水に溶解した後、安全ギヤビネツト内
で孔径0.2μmの除菌フイルターで濾過して試料液
とした。
Next, the whitening effect of glucosamine derivatives, which are the active ingredients of the present invention, on melanin-producing pigment cells (melanotic melanoma cells) will be demonstrated in the following test examples. Example 1 Tetra-O-acetyl-glucosamine hydrochloride Tetra-O-propanoyl-glucosamine hydrochloride N-octanoyl-glucosamine N-acetyl-1,3,4,6-tetra-O-
Propionylglucosamine N-acetyl-1,3,4,6-tetra-O-
Butyrylglucosamine N-acetyl-1,3,4,6-tetra-O-
Acetylglucosamine N-acetyl-3,4,6-tri-O-butyrylglucosamine N-acetyl-3,4,6-tri-O-propionylglucosamine N-acetyl-3,4,6-tri-O-acetyl Glucosamine N-acetyl-1-propionylglucosamine N-butyryl-1,3,4,6-tetra-O-
Butyrylglucosamine O-β-octanoyl-glucosamine acetate N-octadecanoyl-glucosamine O-β-octadecanoyl-glucosamine hydrochloride N-montanoyl-glucosamine N-mericinoyl-glucosamine N-linolenyl-glucosamine N-elcanyl-glucosamine N-acetylglucosamine Glucosamine hydrochloride Hydroquinone Kojic acid Alcorbic acid Preparation of sample solution The test substance was dissolved in pure water to the concentration shown in Tables 1-1 and 1-2, and then placed in a safety gear cabinet with a pore size of 0.2 μm. It was filtered with a sterilization filter and used as a sample solution.

【表】【table】

【表】 色素細胞 色素細胞は培養細胞として確立されているB−
16mouse melanotic型黒色腫細胞を用いた。 試験方法 安全キヤビネツト内において、シヤーレ(60mm
直径)に試料液0.1ml,1.5×105個の色素細胞を含
む培養液0.1ml,10%牛胎児血清を含むイーグル
最小栄養培地3.8mlを加え。炭酸ガス培養器にお
いて5%の炭酸ガスを含有する空気下37℃・6日
間培養した。なお、コントロールは試料液のかわ
りに純水を加え培養した。6日間培養した色素細
胞は、培養液を除去しダルベツコリン酸緩衝液で
洗浄した後、0.025%トリプシンを含むダルベツ
コリン酸緩衝液を加え細胞を剥離した。次いで剥
離した色素細胞に培養液4mlを加え懸濁させ細胞
数の測定を行つた後、1000rpm・10分間遠心して
得られた色素細胞の白色化の程度を肉眼により比
較した。 −1 試験結果 表2−1、表2−2および表2−3に結果を示
す。
[Table] Pigment cells Pigment cells are B- cells that have been established as cultured cells.
16mouse melanotic melanoma cells were used. Test method In a safety cabinet, a shear plate (60mm
diameter), add 0.1 ml of sample solution, 0.1 ml of culture medium containing 1.5 × 10 5 pigment cells, and 3.8 ml of Eagle's minimal nutrient medium containing 10% fetal bovine serum. The cells were cultured in a carbon dioxide incubator at 37°C for 6 days in air containing 5% carbon dioxide. In addition, as a control, pure water was added and cultured instead of the sample solution. The culture medium was removed from the pigmented cells that had been cultured for 6 days, and the cells were washed with Dulbets' choline buffer, followed by the addition of Dulbets' choline buffer containing 0.025% trypsin to detach the cells. Next, 4 ml of culture solution was added to the detached pigment cells to suspend them, and the number of cells was measured, followed by centrifugation at 1000 rpm for 10 minutes, and the degree of whitening of the pigment cells obtained was visually compared. -1 Test results The results are shown in Table 2-1, Table 2-2 and Table 2-3.

【表】【table】

【表】 ※ :白色化度大、+:やや白色化、−:白色化せ

以上の結果より、本発明のグルコサミン誘導体
はグルコサミン塩酸塩より色素細胞に対する白色
化効果が強く、また従来知られているコウジ酸、
アスコルビン酸よりも白色化効果を示すことが認
められた。さらに、ハイドロキノンに比べ細胞毒
性を殆ど示さずに白色化する事が認められた。な
お、炭素数30のアシル基を有するN−メリシノイ
ル−グルコサミンはグルコサミン塩酸塩と同程度
の白色化効果でしかなく、試験に供した炭素数29
以下のアシル基を有するグルコサミン誘導体のい
ずれよりも効果が劣つた。特に炭素数1〜8のア
シル基を有するグルコサミン誘導体がより強い白
色化効果を示した。 試験例 2 試験例1で白色化した細胞について、試験例1
の試験方法に準じ、試験液を加えずに再度培養
し、得られた細胞について白色化の程度を肉眼に
より比較した。 −2 試験結果 表3に結果を示す。
[Table] *: High degree of whitening, +: Slightly whitening, -: No whitening From the above results, the glucosamine derivative of the present invention has a stronger whitening effect on pigment cells than glucosamine hydrochloride, and it also shows that the glucosamine derivative of the present invention has a stronger whitening effect on pigment cells than glucosamine hydrochloride. kojic acid,
It was found to have a more whitening effect than ascorbic acid. Furthermore, whitening was observed with almost no cytotoxicity compared to hydroquinone. Note that N-merisinoyl-glucosamine, which has an acyl group with 30 carbon atoms, has a whitening effect comparable to that of glucosamine hydrochloride;
It was less effective than any of the following glucosamine derivatives having an acyl group. In particular, glucosamine derivatives having an acyl group having 1 to 8 carbon atoms showed a stronger whitening effect. Test Example 2 Regarding the whitened cells in Test Example 1, Test Example 1
The cells were cultured again without adding the test solution according to the test method described above, and the degree of whitening of the obtained cells was visually compared. -2 Test results Table 3 shows the results.

【表】 ※ :白色化度大、+:やや白色化、−:白色化せ

以上の結果より、本発明のグルコサミン誘導体
は色素細胞のメラニン生成を著しく抑制するが、
その効果が可逆的であり細胞の生育には悪影響を
与えないことが認められた。これに対し従来知ら
れているハイドロキノンは、試験液を加えない再
培養においても色素細胞は白色化したままであ
り、また細胞の生育も著しく不良であつた。 試験例 3 試験例1の試験物質を2つ以上混合して、試験
例1の試験方法に準して培養し、得られた細胞に
ついて白色化の程度を肉眼により比較した。 −3 試験結果 表4に結果を示す。
[Table] *: High degree of whitening, +: Slight whitening, -: No whitening From the above results, the glucosamine derivative of the present invention significantly suppresses melanin production in pigment cells;
It was found that the effect was reversible and did not adversely affect cell growth. In contrast, with conventionally known hydroquinone, pigment cells remained white even in re-cultivation without the addition of a test solution, and cell growth was also extremely poor. Test Example 3 Two or more test substances of Test Example 1 were mixed and cultured according to the test method of Test Example 1, and the degree of whitening of the obtained cells was visually compared. -3 Test results Table 4 shows the results.

【表】【table】

【表】 ※ :白色化度大、+:やや白色化、−:白色化せ

以上の結果より、本発明のグルコサミン誘導体
は、1種または2種以上を用いても、その他の還
元性皮膚黒化防止物質を共に用いても、白色化効
果にはほとんど影響がないことが認められた。 試験例 4 年齢21〜61歳までの男性15名、女性15名、計30
名からなる被検者の上腕屈側部に、クローズドパ
ツチテストを実施した。試料としては試験例1の
試験物質の1%溶液を用いた。 判定の基準 −;全く無反応、±;軽微な紅斑、
+;明らかな紅斑、++;紅斑及び腫張、丘疹 −4 試験結果 表5−1および表5−2に結果を示す。
[Table] *: Large degree of whitening, +: Slightly whitening, -: No whitening From the above results, the glucosamine derivative of the present invention has no effect on other reducing skin conditions even when one or more types are used. It was found that even when an anti-blackening substance was used together, the whitening effect was hardly affected. Test example 4 15 men and 15 women between the ages of 21 and 61, total 30
A closed patch test was performed on the flexor side of the upper arm of each subject. A 1% solution of the test substance of Test Example 1 was used as a sample. Judgment criteria -: No reaction at all, ±: Slight erythema,
+: Obvious erythema, ++: Erythema and swelling, papule-4 Test results The results are shown in Table 5-1 and Table 5-2.

【表】【table】

【表】【table】

〔実施例〕〔Example〕

次に本発明の実施例を示す。配合割合は重量部
である。 実施例1 皮膚用ローシヨン ポリオキシエチレン (20)モノオレート 1.0 エタノール 3.0 ポリエチレングリコール600 5.0 クエン酸 0.03 クエン酸ナトリウム 0.2 N−アセチル−1,3,4,6−テトラ−O−
プロピオニルグルコサミン 0.1 メチルパラベン 0.1 香料 適量 水 残余 実施例2 皮膚用パツク ポリビニルアルコール 2 エタノール 20 N−ブチリル−1,3,4,6−テトラ−O−
ブチリルグリコサミン 1 N−オクタノイル−グルコサミン 1 グリセリン 5 香料 適量 水 残余 実施例3 外用クリーム 密ロウ 4.0 ステアリン酸 5.0 セタノール 5.0 ラノリン 3.0 プリスタン3.0 ポリオキシエチレン スナアレート 3.5 グリセリンモノステアレート 1.5 N−オクチル−1,3,4,6−テトラ−O−
ナクチルグルコサミン 5.0 プロピレングリコール 10.0 香料.防腐剤 適量 水 残余 本発明の色白化粧料とアスコルビン酸、コウジ
酸、桂皮アルデヒド等皮膚の黒化を防止する物質
を配合した色白化粧料を用いて、健康な男性の上
腕部における色黒、シミ、ソバカスの防止の使用
テストを行なつたが、ここにおいても本発明の色
白化粧料の効果が格段に優れていることが実証さ
れた。 〔発明の効果〕 以上詳述した如く、本発明は皮膚の黒化を防止
する成分としてグルコサミン誘導体を効果的に配
合した色白化粧料に関するものであり、従来知ら
れている各種アスコルビン酸類、過酸化水素、グ
ルタチオン、コロイド硫黄、コウジ酸、桂皮アル
デヒド等の皮膚の黒化を防止する物質を配合した
色白化粧料と比べ、日光からの紫外線照射によつ
て生じる皮膚の黒化をはるかに防ぐことができ、
皮膚の色黒やシミ、ソバカスの防止、美肌作用等
の効果が優れていると共に、ハイドロキノンにみ
られるような細胞毒性が殆どないため白斑等の弊
害を起こす恐れがなく安全に用いることができる
ものである。
Next, examples of the present invention will be shown. The blending ratio is in parts by weight. Example 1 Skin lotion Polyoxyethylene (20) Monooleate 1.0 Ethanol 3.0 Polyethylene glycol 600 5.0 Citric acid 0.03 Sodium citrate 0.2 N-acetyl-1,3,4,6-tetra-O-
Propionylglucosamine 0.1 Methylparaben 0.1 Fragrance Appropriate amount Water Residual Example 2 Skin pack Polyvinyl alcohol 2 Ethanol 20 N-Butyryl-1,3,4,6-tetra-O-
Butyrylglycosamine 1 N-octanoyl-glucosamine 1 Glycerin 5 Fragrance Appropriate amount Water Remaining Example 3 Topical cream Beeswax 4.0 Stearic acid 5.0 Setanol 5.0 Lanolin 3.0 Pristane 3.0 Polyoxyethylene Sunaate 3.5 Glycerin monostearate 1.5 N-Octyl-1, 3,4,6-tetra-O-
Nactylglucosamine 5.0 Propylene glycol 10.0 Fragrance. Preservative Appropriate amount Water Residual Using the skin lightening cosmetic of the present invention and substances that prevent skin darkening such as ascorbic acid, kojic acid, and cinnamaldehyde, it is possible to prevent dark skin and spots on the upper arms of healthy men. , a use test was conducted to prevent freckles, and it was demonstrated that the fairing cosmetics of the present invention were extremely effective here as well. [Effects of the Invention] As detailed above, the present invention relates to a skin-lightening cosmetic that effectively contains a glucosamine derivative as an ingredient that prevents skin darkening. Compared to skin lightening cosmetics that contain substances that prevent skin darkening such as hydrogen, glutathione, colloidal sulfur, kojic acid, and cinnamaldehyde, this product is far more effective at preventing skin darkening caused by ultraviolet rays from sunlight. I can,
It has excellent effects such as preventing dark skin, age spots, and freckles, and beautifying the skin. It also has almost no cytotoxicity like hydroquinone, so it can be used safely without the risk of causing adverse effects such as vitiligo. It is.

Claims (1)

【特許請求の範囲】 1 式 【化】 (式中、R1,R2,R3,R4,R5は炭素数1〜8
のアシル基を示す)で示されるグリコサミン誘導
体の内1種または2種以上を有効成分として配合
してなる色白化粧料。 2 グルコサミン誘導体の配合量が色白化粧料の
0.001〜10重量%である特許請求の範囲第1項記
載の色白化粧料。
[Scope of Claims] 1 Formula [ Chemical formula ]
A fair-skinned cosmetic containing one or more of the glycosamine derivatives represented by the following acyl groups as an active ingredient. 2 The amount of glucosamine derivatives contained in fair skin cosmetics
The fair-skinned cosmetic according to claim 1, which contains 0.001 to 10% by weight.
JP17735585A 1985-08-12 1985-08-12 Skin-beautifying cosmetic Granted JPS6236306A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17735585A JPS6236306A (en) 1985-08-12 1985-08-12 Skin-beautifying cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17735585A JPS6236306A (en) 1985-08-12 1985-08-12 Skin-beautifying cosmetic

Publications (2)

Publication Number Publication Date
JPS6236306A JPS6236306A (en) 1987-02-17
JPH0581566B2 true JPH0581566B2 (en) 1993-11-15

Family

ID=16029516

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17735585A Granted JPS6236306A (en) 1985-08-12 1985-08-12 Skin-beautifying cosmetic

Country Status (1)

Country Link
JP (1) JPS6236306A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2565513B2 (en) * 1987-09-25 1996-12-18 三省製薬株式会社 Topical drug for suppressing melanin production
JPH02262504A (en) * 1988-12-24 1990-10-25 Rinjiro Saruno Inhibitor of melanin dyestuff formation
JP2585094B2 (en) * 1989-03-16 1997-02-26 株式会社 コーセー Cosmetics
JPH0311019A (en) * 1989-06-08 1991-01-18 Sansho Seiyaku Co Ltd External preparation for inhibiting melanin formation
KR940000166B1 (en) * 1989-11-09 1994-01-08 니혼다바고 상교오 가부시기가이샤 Novel glucosamine derivative and liposome containing the same as membrane component
WO1991007416A1 (en) * 1989-11-09 1991-05-30 Japan Tobacco Inc. Novel glucosamine derivative and liposome containing the same as membrane component
KR940004071B1 (en) * 1990-04-12 1994-05-11 니홍 다바꼬 상교 가부시끼가이샤 4,6-o-hydroxy phosphorylglucosamine derivatives
WO2001001993A1 (en) * 1999-07-02 2001-01-11 Greither, Peter A formulation of glucosamine sulphate
EP1941863A3 (en) * 2002-07-25 2008-12-31 Lion Corporation External preparation composition
DE60225077D1 (en) 2002-07-25 2008-03-27 Lion Corp TOPICAL PREPARATION
CN101177438B (en) * 2002-10-09 2012-05-23 花王株式会社 N-acetylglucosamine derivatives and use thereof
US7393937B2 (en) 2002-10-09 2008-07-01 Kao Corporation N-acetylglucosamine derivatives and use thereof
WO2005074879A1 (en) * 2004-02-04 2005-08-18 Kao Corporation Wrinkle-diminishing agent
EP2094277A4 (en) * 2006-10-20 2010-01-20 Kim Soo Youl A composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
JP5258993B1 (en) * 2012-03-29 2013-08-07 株式会社 資生堂 Heparan sulfate production promoter
US11241374B2 (en) * 2018-06-28 2022-02-08 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using light and glucosamine hydrochloride

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4920762A (en) * 1972-06-20 1974-02-23
JPS5913708A (en) * 1982-07-14 1984-01-24 Shiseido Co Ltd Cosmetic
JPS59157009A (en) * 1983-02-25 1984-09-06 Yakurigaku Chuo Kenkyusho:Kk External skin drug for suppressing formation of melanin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4920762A (en) * 1972-06-20 1974-02-23
JPS5913708A (en) * 1982-07-14 1984-01-24 Shiseido Co Ltd Cosmetic
JPS59157009A (en) * 1983-02-25 1984-09-06 Yakurigaku Chuo Kenkyusho:Kk External skin drug for suppressing formation of melanin

Also Published As

Publication number Publication date
JPS6236306A (en) 1987-02-17

Similar Documents

Publication Publication Date Title
JP4025546B2 (en) Skin beautifying agent, skin anti-aging agent, whitening agent and skin external preparation
JPH0581566B2 (en)
JP4564471B2 (en) Composition suitable for external use
US5601806A (en) Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues
JP2000095663A (en) Agent for external use containing plant extract
EP0345082A2 (en) Enzyme formation suppressing agent
JPS60202806A (en) Whitening cosmetic
JPH05186324A (en) Beautifying cosmetic
JPH05320039A (en) Skin-beautifying cosmetic
KR100389983B1 (en) Skin whitening composition containing arbutin and glucosidase as active ingredients
JPH03275613A (en) Skin external agent
JP4906179B2 (en) Topical skin preparation
JP2003137714A (en) Cosmetic composition or pharmaceutical composition
JP2000344653A (en) Eraser for active oxygen and skin cosmetic
CN114948789A (en) SOD composition with high-efficiency blue light resisting effect and preparation method thereof
EP0345081A2 (en) Enzyme formation suppressing agent
KR101305691B1 (en) Anti-aging composition containing Cellulixir
JP4726505B2 (en) External preparation for skin and skin whitening method
JP4610705B2 (en) Topical skin preparation
JPH02273608A (en) White colored cosmetic stock
JPH04187618A (en) Skin external preparation
JPS6236307A (en) Skin-beautifying cosmetic
JPH05509291A (en) Phenylamine depigmentation, anti-melanoma agent
RU2096032C1 (en) Cosmetic agent
JP4804729B2 (en) Composition for improving peripheral blood circulation